The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond, shaping the future…